# Anti-Drug Antibody Analysis Dataset

Anti-Drug Antibody Analysis Dataset

## Usage

``` r
adab
```

## Format

A data frame with 72 columns:

- STUDYID :

  Study Identifier

- USUBJID :

  Unique Subject Identifier

- SUBJID :

  Subject Identifier for the Study

- SITEID :

  Study Site Identifier

- ASEQ :

  Analysis Sequence Number

- REGION1 :

  Geographic Region 1

- COUNTRY :

  Country

- ETHNIC :

  Ethnicity

- AGE :

  Age

- AGEU :

  Age Units

- SEX :

  Sex

- RACE :

  Race

- SAFFL :

  Safety Population Flag

- TRT01P :

  Description of Planned Arm

- TRT01A :

  Description of Actual Arm

- TRTSDTM :

  Datetime of First Exposure to Treatment

- TRTSDT :

  Date of First Exposure to Treatment

- TRTEDTM :

  Datetime of Last Exposure to Treatment

- TRTEDT :

  Date of Last Exposure to Treatment

- ISSEQ :

  Sequence Number

- ISTESTCD :

  Immunogenicity Test/Exam Short Name

- ISTEST :

  Immunogenicity Test or Examination Name

- ISCAT :

  Category for Immunogenicity Test

- ISBDAGNT :

  Binding Agent

- ISSTRESC :

  Character Result/Finding in Std Format

- ISSTRESN :

  Numeric Results/Findings in Std. Units

- ISSTRESU :

  Standard Units

- ISSTAT :

  Completion Status

- ISREASND :

  Reason Not Done

- ISSPEC :

  Specimen Type

- DTL :

  Drug Tolerance Level

- MRT :

  Minimum Reportable Titer

- VISITNUM :

  Visit Number

- VISIT :

  Visit Name

- VISITDY :

  Planned Study Day of Visit

- EPOCH :

  Epoch

- ISDTC :

  Date/Time of Collection

- ISDY :

  Study Day of Visit/Collection/Exam

- ISTPT :

  Planned Time Point Name

- ISTPTNUM :

  Planned Time Point Number

- PARAM :

  Parameter

- PARAMCD :

  Parameter Code

- PARCAT1 :

  Parameter Category 1

- AVAL :

  Analysis Value

- AVALC :

  Analysis Value (C)

- AVALU :

  Analysis Value Unit

- BASETYPE :

  Baseline Type

- BASE :

  Baseline Value

- CHG :

  Change from Baseline

- DTYPE :

  Derivation Type

- ADTM :

  Analysis Datetime

- ADT :

  Analysis Date

- ADY :

  Analysis Relative Day

- ATMF :

  Analysis Time Imputation Flag

- AVISIT :

  Analysis Visit

- AVISITN :

  Analysis Visit (N)

- ATPT :

  Analysis Timepoint

- APHASE :

  Phase

- APHASEN :

  Phase (N)

- APERIOD :

  Period

- APERIODC :

  Period (C)

- FANLDTM :

  First Datetime of Dose for Analyte

- FANLDT :

  First Date of Dose for Analyte

- FANLTM :

  First Time of Dose for Analyte

- FANLTMF :

  First Time of Dose for Analyte ImputeFL

- NFRLT :

  Nom. Rel. Time from Analyte First Dose

- AFRLT :

  Act. Rel. Time from Analyte First Dose

- FRLTU :

  Rel. Time from First Dose Unit

- ABLFL :

  Baseline Record Flag

- ADABLPFL :

  Baseline ADA Eval. Param-Level Flag

- ADPBLPFL :

  Post-Baseline ADA Eval. Param-Level Flag

- ADAFL :

  ADA Population Flag

## Source

Generated from admiral package (template ad_adab.R).

## Details

Contains a set of 22 unique Parameter Codes and Parameters:

|             |                                                                              |
|-------------|------------------------------------------------------------------------------|
| **PARAMCD** | **PARAM**                                                                    |
| ADADUR1     | ADA Duration (Weeks), Anti-XANOMELINE Antibody (1)                           |
| ADASTAT1    | ADA Status of a patient, Anti-XANOMELINE Antibody (1)                        |
| ADASTTV1    | ADA Status of a patient by Visit, Anti-XANOMELINE Antibody (1)               |
| BABXANOM    | Anti-XANOMELINE Antibody, Titer Units (1)                                    |
| BFLAG1      | Baseline Pos/Neg, Anti-XANOMELINE Antibody (1)                               |
| EMERNEG1    | Treatment Emergent - Negative, Anti-XANOMELINE Antibody (1)                  |
| EMERPOS1    | Treatment Emergent - Positive, Anti-XANOMELINE Antibody (1)                  |
| ENHANC1     | Treatment enhanced ADA, Anti-XANOMELINE Antibody (1)                         |
| FPPDTM1     | First Post Dose Positive Datetime, Anti-XANOMELINE Antibody (1)              |
| INDUCD1     | Treatment induced ADA, Anti-XANOMELINE Antibody (1)                          |
| LPPDTM1     | Last Post Dose Positive Datetime, Anti-XANOMELINE Antibody (1)               |
| NABSTAT1    | Nab Status, Anti-XANOMELINE Neutralizing Antibody (1)                        |
| NABXANOM    | Anti-XANOMELINE Neutralizing Antibody (1)                                    |
| NOTRREL1    | No treatment related ADA, Anti-XANOMELINE Antibody (1)                       |
| PBFLAGV1    | Post Baseline Pos/Neg by Visit, Anti-XANOMELINE Antibody (1)                 |
| PERSADA1    | Persistent ADA, Anti-XANOMELINE Antibody (1)                                 |
| RESULT1     | ADA interpreted per sample result, Anti-XANOMELINE Antibody (1)              |
| RESULT2     | Nab interpreted per sample result, Anti-XANOMELINE Neutralizing Antibody (2) |
| TFLAGV1     | Treatment related ADA by Visit, Anti-XANOMELINE Antibody (1)                 |
| TIMADA1     | Time to onset of ADA (Weeks), Anti-XANOMELINE Antibody (1)                   |
| TRANADA1    | Transient ADA, Anti-XANOMELINE Antibody (1)                                  |
| TRUNAFF1    | Treatment unaffected, Anti-XANOMELINE Antibody (1)                           |

## References

None

## Examples

``` r
data("adab")
```
